Cargando…
PD-L1(+)CD8(+) T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance
Immunotherapy targeting checkpoint blockade to rescue T cells from exhaustion has become an essential therapeutic strategy in treating cancers. Till now, little is known about the PD-L1 graphic pattern and characteristics in CD8(+) T cells. We combined cytometry by time-of-flight (CyTOF) and imaging...
Autores principales: | Zheng, Yingxia, Han, Li, Chen, Zheyi, Li, Yiyang, Zhou, Bingqian, Hu, Rui, Chen, Shiyu, Xiao, Haibo, Ma, Yanhui, Xie, Guohua, Yang, Junyao, Ding, Xianting, Shen, Lisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819393/ https://www.ncbi.nlm.nih.gov/pubmed/35146396 http://dx.doi.org/10.1016/j.isci.2022.103785 |
Ejemplares similares
-
PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer
por: Hu, Rui, et al.
Publicado: (2022) -
Interleukin 32 Promotes Foxp3(+) Treg Cell Development and CD8(+) T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment
por: Han, Li, et al.
Publicado: (2021) -
Prmt5 deficiency inhibits CD4+ T-cell Klf2/S1pr1 expression and ameliorates EAE disease
por: Zheng, Yingxia, et al.
Publicado: (2023) -
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment
por: Zheng, Yingxia, et al.
Publicado: (2020) -
CD19(+)CD24(hi)CD38(hi)Bregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer
por: Wang, Weiwei, et al.
Publicado: (2015)